(Q43108151)

14 November 2017

The suspension of treatments in ADAPT: concerns beyond the cardiovascular safety of celecoxib or naproxen (English)

1 reference

14 November 2017

1 reference

John C S Breitner

1

1 reference

14 November 2017

Barbara K Martin

series ordinal

2

1 reference

14 November 2017

Curtis L Meinert

series ordinal

3

1 reference

14 November 2017

22 December 2006

1 reference

14 November 2017

1 reference

14 November 2017

1

1 reference

14 November 2017

8

1 reference

14 November 2017

e41

1 reference

Creative Commons Attribution 4.0 International

14 November 2017

start time

22 December 2006

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

ADAPT: the wrong way to stop a clinical trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1713263

PubMed Central

reference URL

Cardiovascular and cerebrovascular events in the randomized, controlled Alzheimer's Disease Anti-Inflammatory Prevention Trial (ADAPT)

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1713263

PubMed Central

reference URL

10.1371/JOURNAL.PCTR.0010041

25 May 2018

Identifiers

DOI

1 reference

14 November 2017

1 reference

14 November 2017

PubMed publication ID

17192795

1 reference